Entering text into the input field will update the search result below

Horizon Therapeutics rises in premarket after earnings beat, 2022 guidance

Mar. 01, 2022 9:26 AM ETHorizon Therapeutics Public Limited Company (HZNP)By: Jonathan Block, SA News Editor

Rolled newspaper with the headline Quarterly Results

Zerbor/iStock via Getty Images

  • Shares of Horizon Therapeutics (NASDAQ:HZNP) are trading 4% higher in the premarket session after its Q4 2021 results beat on the top and bottom lines and it issued 2022 guidance.
  • Net income in the quarter dropped ~9% to $173.2M compared

Recommended For You


Have a tip? Submit confidentially to our News team. Found a factual error? Report here.

Related Stocks

SymbolLast Price% Chg
Horizon Therapeutics Public Limited Company
Arrowhead Pharmaceuticals, Inc.
Amgen Inc.
Summit Therapeutics Inc.
VMware, Inc.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.